您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > CSRM617 hydrochloride
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
CSRM617 hydrochloride
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
CSRM617 hydrochloride图片
CAS NO:1353749-74-2
包装与价格:
包装价格(元)
5mg电议
10mg电议
50mg电议

产品介绍
CSRM617 hydrochloride 是转录因子ONECUT2(OC2,雄激素受体 AR 的主要调节剂) 的选择性小分子抑制剂,在 SPR 测定中Kd为 7.43 uM,直接与 OC2-HOX 结构域结合。CSRM617 hydrochloride 通过切割 Caspase-3 和 PARP 诱导细胞凋亡 (apoptosis)。CSRM617 hydrochloride 在小鼠的前列腺癌模型中耐受性良好。
生物活性

CSRM617 hydrochloride is a selective small-molecule inhibitor ofthe transcription factor ONECUT2(OC2, a master regulator of androgen receptor) with aKdof 7.43 uM in SPR assays, binding to OC2-HOX domain directly. CSRM617 hydrochloride inducesapoptosisby appearance of cleaved Caspase-3 andPARP. CSRM617 hydrochloride is well tolerated in the prostatecancermouse model[1]

体外研究
(In Vitro)

CSRM617 (0.01-100 μM; 48 hours) hydrochloride inhibits cell growth in several PC cell lines: PC-3, 22RV1, LNCaP, C4-2 cells[1].
CSRM617 (10-20 μM; 48 hours) hydrochloride induces apoptosis in 22Rv1 cells results in cell death in a concentration-dependent fashion[1].
CSRM617 (20 μM; 72 hours) hydrochloride induces apoptosis in 22Rv1 cells by appearance of cleaved Caspase-3 and PARP[1].

体内研究
(In Vivo)

CSRM617 (50 mg/kg; p.o.; daily, for 20 d) inhibits tumor growth in SCID mice with 22Rv1 xenograft[1].

Animal Model:SCID mice with 22Rv1 xenograft[1]
Dosage:50 mg/kg
Administration:Oral administration; daily, for 20 days
Result:Elicited a significant reduction in the onset and growth of diffuse metastases.
分子量

291.69

性状

Solid

Formula

C10H14ClN3O5

CAS 号

1353749-74-2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

-20°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)